Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccines”

603 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 603 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05314023
What this trial is testing

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Who this might be right for
Genital Warts
Merck Sharp & Dohme LLC 1,590
Not applicableLooking for participantsNCT06513494
What this trial is testing

Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial

Who this might be right for
Vaccine RefusalVaccine Hesitancy
Hospital Israelita Albert Einstein 5,000
Large-scale testing (Phase 3)Study completedNCT00779766
What this trial is testing

Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 6,081
Post-approval studies (Phase 4)UnknownNCT04270773
What this trial is testing

Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women

Who this might be right for
HIV InfectionsHPV Infection
University Hospital Virgen de las Nieves 158
Not applicableLooking for participantsNCT06808776
What this trial is testing

Stories to Prevent (StoP) HPV Cancers

Who this might be right for
Human Papillomavirus VaccinationEmotions
Milton S. Hershey Medical Center 200
Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Not applicableLooking for participantsNCT06862102
What this trial is testing

Multiple Human Papillomavirus Infections in the Development of CIN

Who this might be right for
CIN - Cervical Intraepithelial NeoplasiaHPVHPV Vaccines
Fondazione IRCCS Policlinico San Matteo di Pavia 152
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Large-scale testing (Phase 3)Study completedNCT00637195
What this trial is testing

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 152
Testing effectiveness (Phase 2)Study completedNCT00359619
What this trial is testing

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 383
Testing effectiveness (Phase 2)UnknownNCT04096911
What this trial is testing

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsCervical CancerCervical Neoplasms+1 more
Buhai Wang 20
Post-approval studies (Phase 4)Study completedNCT02236234
What this trial is testing

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil

Who this might be right for
Infection
University of Sao Paulo 30
Not applicableStudy completedNCT07320157
What this trial is testing

The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake

Who this might be right for
HPV (Human Papillomavirus)-AssociatedHPV Immunization Status
Ufuk University 59
Large-scale testing (Phase 3)Study completedNCT00169494
What this trial is testing

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 770
Testing effectiveness (Phase 2)Study completedNCT00604175
What this trial is testing

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 319
Post-approval studies (Phase 4)Study completedNCT01043341
What this trial is testing

Knowledge and Attitude About HPV Vaccines

Who this might be right for
KnowledgeAttitudeBehavior
Universidade Cidade de Sao Paulo 200
Not applicableStudy completedNCT02897232
What this trial is testing

Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination

Who this might be right for
Papillomavirus InfectionsHealth BehaviorAttitude of Health Personnel+1 more
Louisiana State University Health Sciences Center Shreveport 386
Not applicableUnknownNCT04905030
What this trial is testing

Education, Immigration and HPV Vaccination: an Informational Randomized Trial

Who this might be right for
Cervical CancerVulvar CancerAnus Cancer+5 more
Karolinska Institutet 2,500
Not applicableStudy completedNCT04279964
What this trial is testing

Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake

Who this might be right for
Primary Prevention
University of Colorado, Denver 2,400
Early research (Phase 1)Study completedNCT00988559
What this trial is testing

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Who this might be right for
HPV16 PositiveCervical Intraepithelial Neoplasia (CIN 2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 132
Next Page